Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Addressing the intersection between COVID-19 and young people vaping: timely resources needed

Nilanga Aki Bandara, Jay Herath and Vahid Mehrnoush
CMAJ October 26, 2020 192 (43) E1310; DOI: https://doi.org/10.1503/cmaj.76793
Nilanga Aki Bandara
Teaching assistant, University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jay Herath
Instructor, University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vahid Mehrnoush
Postdoctoral research fellow, University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Gagnon’s article1 highlights the urgent need for resources to be created so that health care professionals can have discussions with their young patients about vaping. No validated screening tools exist to discuss vaping with young patients, and almost one-third of Canadian pediatricians find it challenging to discuss vaping with patients and their family members.1 Thus, it is clear that health care professionals lack sufficient knowledge and adequate resources when supporting young patients who vape. Also, there are no Canadian guidelines available to guide clinicians’ clinical decision-making on vaping; the only available guideline recommendations concluded that “[t]here is no conclusive evidence on the potential harmful effects of e-cigarettes or whether they can be used in smoking cessation interventions for either adults or youth.”2

Recent research shows a strong association between coronavirus disease 2019 (COVID-19) diagnosis and a history of e-cigarette use in young people.3 Therefore, it is of utmost importance that clinical guidelines and evidence-based tools are created quickly to empower health care professionals and facilitate conversation in clinical encounters on the value of nicotine-free lifestyles for our younger generation, given that both COVID-19 and vaping affect the lungs. The most recent position paper on e-cigarettes, published in the European Journal of Preventive Cardiology,4 encourages public campaigns to raise awareness of vaping’s adverse effects and prevent initiation of vaping, and advises that health professionals inform their patients and the general public about the possible adverse health risks of e-cigarette smoking.

Unsurprisingly, the e-cigarette industry appears to have taken advantage of the COVID-19 pandemic to aggressively market its products.5 Marketing strategies include providing pandemic-related discounts, asserting health claims and assuring consumers that e-cigarette products will not transmit severe acute respiratory syndrome coronavirus 2.5 Such marketing may appear attractive to young people and encourage them to vape.

Physicians urgently need to be educated about the risks of vaping, which requires investment in the creation of suitable Canadian clinical guideline resources. In the meantime, Canadian health care professionals should consider using the US National Institute of Drug Abuse Screening to Brief Intervention tool (S2BI) or the Brief Screener for Tobacco, Alcohol, and other Drugs (BSTAD) tool among adolescent patients.6 These tools take less than 2 minutes to administer and were validated with adolescent populations.6 These tools also offer guidance regarding next steps to support pediatric patients.6

Additionally, the Centers for Disease Control and Prevention has an excellent resource that supports health care professionals in starting conversations on vaping.7 This resource encourages practitioners to empathetically communicate in a nonjudgmental manner and ask all patients about vaping use, recommending that parents be asked to leave the room to facilitate discussions with minors.7 This tool provides guidance on asking questions on vaping using a “what, how and where” framework.7

Footnotes

  • Competing interests: None declared.

References

  1. ↵
    1. Gagnon L
    . How many Canadian kids suffer harm linked to vaping and cannabis? CMAJ 2020;192: E1024–5.
    OpenUrlFREE Full Text
  2. ↵
    Canadian Task Force on Preventive Health Care. Recommendations on behavioural interventions for the prevention and treatment of cigarette smoking among school-aged children and youth. CMAJ 2017;189:E310–6.
    OpenUrlFREE Full Text
  3. ↵
    1. Gaiha SM,
    2. Cheng J,
    3. Halpern-Felsher B
    . Association between youth smoking, electronic cigarette use, and coronavirus disease 2019. J Adolesc Health 2020 Aug. 11 [Epub ahead of print]. doi: 10.1016/j.jadohealth.2020.07.002.
    OpenUrlCrossRef
  4. ↵
    1. Kavousi M,
    2. Pisinger C,
    3. Barthelemy J-C,
    4. et al
    . Electronic cigarettes and health with special focus on cardiovascular effects: position paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020 July 29 [Epub ahead of print]. doi: 10.1177/2047487320941993.
    OpenUrlCrossRef
  5. ↵
    1. Ramamurthi D,
    2. Chau C,
    3. Jackler RK
    . Exploitation of the COVID-19 pandemic by e-cigarette marketers. Tob Control 2020 Aug. 27 [Epub ahead of print]. doi: 10.1136/tobaccocontrol-2020-055855.
    OpenUrlFREE Full Text
  6. ↵
    Screening tools for adolescent substance use. Bethesda (MD): National Institute on Drug Abuse; 2019. Available: www.drugabuse.gov/nidamed-medical-health-professionals/screening-tools-resources/screening-tools-for-adolescent-substance-use (accessed on 2020 Sept. 3).
  7. ↵
    Don’t forget to ask: assessing the risk of lung injury in patients using e-cigarette, or vaping, products. Atlanta: Centres for Disease Control and Prevention; 2019. Available: www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease/healthcare-providers/pdfs/dont-forget-to-ask-assessing-the-risk-of-lung-injury-508.pdf (accessed on 2020 Sept. 3).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (43)
CMAJ
Vol. 192, Issue 43
26 Oct 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Addressing the intersection between COVID-19 and young people vaping: timely resources needed
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Addressing the intersection between COVID-19 and young people vaping: timely resources needed
Nilanga Aki Bandara, Jay Herath, Vahid Mehrnoush
CMAJ Oct 2020, 192 (43) E1310; DOI: 10.1503/cmaj.76793

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Addressing the intersection between COVID-19 and young people vaping: timely resources needed
Nilanga Aki Bandara, Jay Herath, Vahid Mehrnoush
CMAJ Oct 2020, 192 (43) E1310; DOI: 10.1503/cmaj.76793
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • How many Canadian kids suffer harm linked to vaping and cannabis?
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • An expanded role for blood donor emerging pathogens surveillance
  • Beyond wastewater surveillance: refining environmental pathogen detection in the built environment
  • Observational evidence in support of screening for depression during pregnancy and the postpartum period
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire